Trellus Health plc (AIM:TRLS)

Market Cap	516.14K -82.7%
Revenue (ttm)	262.03K +552.7%
Net Income	-5.03M
EPS	-0.03
Shares Out	430.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,431
Open	0.1200
Previous Close	0.1250
Day's Range	0.1200 - 0.1200
52-Week Range	0.1011 - 2.3360
Beta	2.58
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 8, 2026

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2020
• Employees: 18
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TRLS

Financial Performance

In 2024, Trellus Health's revenue was $114,000, an increase of 500.00% compared to the previous year's $19,000. Losses were -$7.78 million, 22.8% more than in 2023.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 17, 2026

Data Sources Report a data error